Arbutus Biopharma Corp

NASDAQ:ABUS   1:00:00 PM EDT
3.24
+0.05 (+1.57%)
4:49:34 PM EDT: $3.24 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)630.29M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.61 Million
Adjusted EPS-$0.04
See more estimates
10-Day MA$3.25
50-Day MA$3.35
200-Day MA$3.48
See more pivots

Arbutus Biopharma Corp Stock, NASDAQ:ABUS

701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974
United States of America
Phone: +1.267.469.0914
Number of Employees: 73

Description

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.